BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 117179
Published online Jun 27, 2026. doi: 10.4240/wjgs.117179
Table 1 Comparison of baseline demographic and clinical characteristics between groups, mean ± SD
Variable
Intervention group (n = 60)
Control group (n = 58)
t/χ2
P value
Age (years)63.40 ± 8.7064.10 ± 9.200.4250.672
Female/male26/3430/300.2900.590
BMI (kg/m2)23.80 ± 3.1024.20 ± 3.400.6680.505
Surgery type (gastric/colorectal/pancreatic)22/25/1320/26/120.1210.941
Duration of surgery (hours)4.20 ± 1.104.40 ± 1.300.9030.368
APACHE II score16.30 ± 3.2016.80 ± 3.500.8100.419
POD subtype (hyperactive/mixed)39/2137/210.0200.991
Pre-operative MMSE score27.40 ± 1.8027.10 ± 2.000.8570.393
Table 2 Comparison of primary and secondary clinical outcomes between groups, n (%)/mean ± SD
Outcome
Intervention group (n = 60)
Control group (n = 58)
t/χ2
P value
Incidence of UE2 (3.33)9 (15.52)0.028
Duration of mechanical ventilation (days)4.23 ± 1.626.14 ± 2.315.2140.000
Duration of stay in ICU (days)6.82 ± 2.119.34 ± 3.065.2230.000
Duration of delirium (days)2.12 ± 0.913.73 ± 1.417.3940.000
Composite post-reintubation complications0 (0.00)5 (8.62)0.026
Drug-related adverse events (total)15 (25.00)19 (32.76)0.8660.352
Table 3 Nursing intervention response efficiency, restraint management, and quality indicators, mean ± SD/n (%)
Indicator
Intervention group (n = 60)
Control group (n = 58)
t/χ2
P value
Intervention response time (seconds)48.22 ± 15.6182.74 ± 24.329.2070.000
Restraint usage rate15 (25.00)26 (44.83)5.1140.024
Duration of restraint (hours)1.85 ± 0.613.53 ± 1.229.5090.000
Restraint-related skin injury1 (1.67)7 (12.07)0.031
CPOT assessment completion rate59 (98.33)42 (72.41)0.000
CAM-ICU assessment completion rate58 (96.67)40 (68.97)0.000
Timely recognition of extubation intention behaviors55 (91.67)36 (62.07)0.000
Pre-restraint communication documentation rate53 (88.33)31 (53.45)17.5000.000
Skin care implementation rate57 (95.00)45 (77.59)0.007
Table 4 Sedation-delirium coupling status and quantified extubation intention behaviors, mean ± SD
Indicator
Intervention group (n = 60)
Control group (n = 58)
t
P value
Mean daily fluctuation in RASS score0.86 ± 0.311.52 ± 0.617.4460.000
Frequency of extubation intention behaviors (times/24 hours)1.22 ± 0.573.65 ± 0.9317.1770.000
CAM-ICU positive days (%)31.26 ± 7.4248.64 ± 9.3511.2040.000
Table 5 Comparison of neuroinflammatory and brain injury biomarker levels, mean ± SD
Biomarker (unit)
Timepoint
Intervention group (n = 60)
Control group (n = 58)
F (group/time/interaction)
P value
IL-6 (pg/mL)Post-op day 185.40 ± 22.3087.20 ± 24.10
Post-op day 342.10 ± 12.6076.50 ± 18.90165.600/151.500/35.5900.000
Post-op day 528.70 ± 8.4065.30 ± 15.20
S100β (ng/mL)Post-op day 10.48 ± 0.120.49 ± 0.13
Post-op day 30.32 ± 0.080.45 ± 0.1192.500/75.460/20.0200.000
Post-op day 50.24 ± 0.060.41 ± 0.09
NSE (ng/mL)Post-op day 118.60 ± 4.2018.90 ± 4.50
Post-op day 314.30 ± 3.1017.80 ± 4.0046.780/41.960/9.6920.000
Post-op day 512.10 ± 2.8016.50 ± 3.70
Table 6 Multivariate Cox regression analysis of unplanned extubation risk (n = 118)
Predictor
Comparison
HR
95%CI
P value
Mean daily fluctuation in RASS score> 1.5 vs ≤ 1.53.8501.421-10.4470.008
Frequency of extubation intention behaviors≥ 3 times/24 hours vs < 3 times/24 hours4.2101.561-11.3660.005
Reduction in the IL-6 level on post-op day 3< 30% vs ≥ 30%2.9301.101-7.8180.031
Intervention response time> 60 seconds vs ≤ 60 seconds3.1201.181-8.2380.022
Restraint usage rateHigh (> 50% of ICU days) vs low2.7801.051-7.3580.039
Nursing assessment completion rateLow (< 90%) vs high (≥ 90%)3.0501.142-8.1470.026


Write to the Help Desk